… ACE inhibitors were discontinued because of adverse drug events. … drug events: age, female
gender, ethnicity other than African American or Latino, no history of previous ACE inhibitor …

… Drugs that function as enzyme inhibitors constitute a significant portion of the orally bioavailable
therapeutic agents that are in clinical use today. Likewise, much of drug … events in vivo. …

… patient monitoring are important when ACE inhibitor therapy is used for any indication.
Provided these steps are taken, ACE inhibitors are generally a safe and effective class of drugs. …

… , Evaluation of Enzyme Inhibitors in Drug Discovery equips … of drugs that work by inhibiting
specific enzyme targets. … of enzyme inhibition and special treatments for enzymes that …

… Profound changes in drug metabolizing enzyme (DME) expression occurs during development
that impacts the risk of adverse drug events in the fetus and child. A review of our current …

… Angiotensin-converting–enzyme inhibitors improve the outcome among patients with left …
–enzyme inhibitor, ramipril, in patients who were at high risk for cardiovascular events but …

… , diseases, enzyme inhibitors, and their attendant clinical benefits. This … enzyme inhibitors.
Accordingly, this review is structured towards this end, with an emphasis on molecular events …

… or prevention of ischemic events. A prudent action is the assumption that the benefits of a
particular ACE inhibitor apply primarily to the investigated indication, doses and outcomes. …

… of ACE inhibitors. ACE has a … enzyme (ACE) inhibitors and their role in the renin–angiotensin
system (RAS) are described, and pharmacokinetic properties and common adverse events …

… of ADRs due to angiotensin-converting enzyme Inhibitors in cardiology department. … -risk
patients suffering from cardiovascular events. ACE inhibitors have specific effect on myocardial …